Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Lets be honest here..."they have made no official announcements about anything except that they will be self-sufficient in 2019."
What about these announcements in February 2019.....
CaverStem™ domestic activities: In 2019, using our Generation 2 bone marrow aspiration system, we have already trained 2 physicians and are training 3 additional physicians in March and April. As additional physicians become involved we will schedule training and marketing campaigns.
"Never tell anyone what you are going to do till you've done it."
Cornelius Vanderbilt
Think CaverStem 3.0 :)
Except .07 was the 52 week high.
I think there are many of those going on behind the scenes.
I know a few who are holding plenty of cash for the right entry point or time, whatever hits first.
Seeing the new doctors sign up and knowing there are at least 3 more scheduled for training was a key factor. That, and knowing we are in a great window for the results.
If the ASK hits .0068 I will have to sell my other kidney.
Still not seeing it. I will keep looking.
One of these?
NEWS: Our collaborators in Neurology just received FDA clearance using our Allogenic Jadi Cell for serial dosing in Alzheimer’s patients. Great work Team. #Alzheimers #cell #biotech #brain #health
— Dr Amit Patel (@DoctorAmitPatel) March 13, 2019
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients | NEJM https://t.co/9hrM6ubxnY
— Dr Amit Patel (@DoctorAmitPatel) March 16, 2019
BREAKING NEWS. We were just notified that our patent on our off the shelf allogenic cells which are currently made GMP will be allowed in Japan🙏🏼 #cell #japan #STEMcells #biotech
— Dr Amit Patel (@DoctorAmitPatel) March 4, 2019
BREAKING NEWS. We were just notified that our patent on painting cells, exosomes, etc to tract directly to targeted organs without impacting their biology will be issued by USPTO. 🙏🏼 #cell #gene #biotech #polymer
— Dr Amit Patel (@DoctorAmitPatel) February 7, 2019
Link please, I might have missed it. Unless it was the update on one of the patents he filed. You do know he is on the BOD, not one of the treating doctors? Dr. Patel - Chief of Cardiac Surgery at the University of Miami Health System. Dr. Patel has an MD from Case Western Reserve University. Dr. Patel is an accomplished inventor and has contributed to the formulation of the Company’s Bionutraceutical® products.
Awesome guy to have on the CMTH team IMO
THANK you for backing down and clarifying.
Earlier you clearly said that the signed doctors were in no hurry to get moving or advertise their own practices intimating they were paid consultants. “Is this the reason these doctors aren't in any hurry whatsoever to do their own independent ad campaigns??? Hmmm, free shares at a 30% discount...sweeeeeeeeeeeeeeeeeeeeet….” “Sounds exactly like the doctors on twitter and youtube.”
Now you are clarifying that the DIRECTORS are the paid consultants. No kidding. Been in the filings since 2016.
Thanks for clarifying and retracting your accusations that the treating doctors are anything more that private practices offering CaverStem and FemCelz.
Glad we got that behind us.
Could this be a reason why some of us perceive CMTH to be quiet? I hope so.
"Never tell anyone what you are going to do till you've done it."
Cornelius Vanderbilt - One of the richest men of all time.
Great DD there. 11 patents. Very nice. Pretty elaborate for a scam company you claim it to be.
And there you go mixing apples to oranges and asking leading questions. I think anyone would be able figure out that a company specializing in stem cell research and patenting procedures would have consultants in the fields of physicians, scientists and other medical specialists.
You conclusions that if they have any physicians that are in fact consultants, that somehow that is evidence that the treating doctors are paid by CMTH is ludicrous.
I think NSX said it best, the treating doctors have private practices and not employees or paid by the company.
You claim you are all just about the facts. Show me any facts, any at all to support your allegation that they are paid consultants. I will wait........
If you have that kind of dedication to spend so much time reading every word of every filing of a company run by such successful people, and then simply have to twist the meaning of the words and still cannot find any faults that makes any sense, it sure makes me feel even better about my investment here.
All that hard work and one can only find that an address used at the time of a filing years ago has seems to have a broken window in the google street view image from an unknown date, or make a strange interpretation of words trying to convince people that the participating doctors are considered “consultants” or trying to show that anyone associated with the company had a compliant filed on them at one time, is all that can be found..... that is awesome.
Deep deep searching has found nothing of significance. Excellent DD IMO, and calming for many longs.
Smart plan IMHO
+100. Perfect analogy sir.
Nice post DD75.
Some are advertising, I posted the link a couple days ago. Out for a bit, play nice :)
Bring it back down to .007 again please. I would love to by those, I missed them last time.
All part of the game gint. Pretty transparent. I missed the .007’s last time too.
Like we have been saying WHC.... there really is tons of info out there if one wants to see it.
These are NOT normal OTC folks. Doctors and scientists who are ONLY interested In getting CaverStem and FemCelz up running and treating patients. The PPS will find its way.
I am sadly holding several thousand to pay my taxes..... but if folks want to bail in the 9th inning, I hope they sell it down to the low .007’s again. I missed those last time. ;)
Seriously.????
NO NEWS WHATSOEVER FROM MANAGEMENT ABOUT ANYTHING. Wrong, they issue shareholder updates approximately monthly, and update social media frequently, in fact important updates were out this previous weekend.
NO TARGET DATE FOR EFFICACY REPORT. Wrong, they are not in control of it, cannot issue a target date, and would be foolish to do so.
NO COMMENT ON NON-STOP MANIPULATION. I’m not even going there, but you get my drift.
Sucks to be them IMHO
Mind you, it says newsletter. Not shareholder update. I am thinking the newsletter will be all marketing stuff to perpetuate the scam LOLOL
CaverStem Facebook page
Ummmm. That’s while you file a late notice, to comply with the reporting rules and regs ;)
I wonder if Medistem looked like a scam back in the day? Never mind, it doesn’t matter.
We have gone over this ad nauseoum. Monthly updates from a QB filer, who has a CEO and COO who won’t chat things up with a shareholder pissed off that he has not tripled his investment, and watching patented procedures come online with accredited physicians is so far the opposite from a scam company I just can’t seem to grasp that conclusion. I seriously can’t.
Good luck to you Wolf.
Seriously. I see it the exact opposite. The interest from doctors around the world and from different fields, institutional investors that just reworked the latest notes into next year, and all the different stem patents and procedures is EXACTLY why I am invested here. It’s the elephant that is about to walk out onto the world stage IMO.
Being a few days late like that I see frequent. I have seen it on many stocks.
Correctomundo
It’s not when I expect it, the rules are that the 10k is due by April 1, and the Q1 is due by May 15.
Good points PhD.
Especially foolish (IMO) to sell before the Q1 that will have obvious evidence of the revenue from the treating physicians
IMO, nothing has changed in the fundamentals of the company except a few iHub’ers don’t like that the COO won’t give them peak under the hood.
Docs signing, advertising starting, a second revenue stream (FemCelz) firing up, and folks want to leave the game in the top of the ninth.
SMH